0001358403-18-000027.txt : 20180222 0001358403-18-000027.hdr.sgml : 20180222 20180222160413 ACCESSION NUMBER: 0001358403-18-000027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180220 FILED AS OF DATE: 20180222 DATE AS OF CHANGE: 20180222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HARRIGAN EDMUND CENTRAL INDEX KEY: 0001177917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 18632513 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_151933343834183.xml FORM 4 X0306 4 2018-02-20 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001177917 HARRIGAN EDMUND C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030 1 0 0 0 Stock Option (right to buy) 6.91 2018-02-20 4 A 0 20000 0 A 2028-02-19 Common Stock 20000.0 20000 D Stock Option (right to buy) 6.91 2018-02-20 4 A 0 3166 0 A 2028-02-19 Common Stock 3166.0 23166 D The stock option vests and becomes exercisable in 36 equal monthly installments from the date of grant, and will vest in full upon a change in control. The stock option vests and becomes exercisable in equal installments on each of March 20, April 20, May 20, and June 14, 2018, and will vest in full upon a change in control. /s/ Alan Musso, Attorney-in-Fact 2018-02-22